Biogenerics at the crossroads

被引：12

作者：

Ben-Maimon, CS ^{[1
]}

Garnick, R ^{[1
]}

机构：

[1] Barr Pharmaceut, Woodcliff Lake, NJ 07677 USA

来源：

NATURE BIOTECHNOLOGY | 2006年 / 24卷 / 03期

关键词：

D O I：

10.1038/nbt0306-268a

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Two executives-one from a leading generics manufacturer, the other from a leading brand manufacturer-argue the pros and cons of implementing an abbreviated US regulatory framework for the approval of biogeneric products.

引用

页码：268 / 269

页数：2

共 50 条

[1] Biogenerics at the crossroads
Carole S Ben-Maimon
Rob Garnick
[J]. Nature Biotechnology, 2006, 24 : 268 - 268
[2] Erratum: Biogenerics at the crossroads
Carole S Ben-Maimon
Rob Garnick
[J]. Nature Biotechnology, 2006, 24 (4) : 467 - 467
[3] Biogenerics at the crossroads (vol 24, pg 268, 2006)
Ben-Maimon, CS
Garnick, R
[J]. NATURE BIOTECHNOLOGY, 2006, 24 (04) : 467 - 467
[4] Biogenerics on horizon
Dorey, Emma
[J]. CHEMISTRY & INDUSTRY, 2007, (04) : 10 - 10
[5] Betting on biogenerics
Alan Dove
[J]. Nature Biotechnology, 2001, 19 : 117 - 120
[6] Biogenerics standoff
Herrera, S
[J]. NATURE BIOTECHNOLOGY, 2004, 22 (11) : 1343 - 1346
[7] Betting on biogenerics
Griffiths, S
[J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (03) : 197 - 198
[8] The advent of biogenerics
De Maria, Gayle
[J]. CHIMICA OGGI-CHEMISTRY TODAY, 2007, 25 (02) : 2 - 2
[9] Betting on biogenerics
Dove, A
[J]. NATURE BIOTECHNOLOGY, 2001, 19 (02) : 117 - 120
[10] Betting on biogenerics
Suzanne Griffiths
[J]. Nature Reviews Drug Discovery, 2004, 3 : 197 - 198

← 1 2 3 4 5 →